The researchers are now working with the pharmaceutical industry to improve the compounds so they can be tested on human patients.
The experiment is particularly significant because it took place in human cells.
Yadong Huang, who led the study, which is published in Nature Medicine, said: “Drug development for Alzheimer’s disease has been largely a disappointment over the last 10 years.
“Many drugs work, beautifully in a mouse model, but so far they’ve all failed in clinical trials.
Recent Comments